Hagens berman, national trial attorneys, alerts fibrogen (fgen) investors to filing of securities fraud class action and encourages investors with losses to contact its attorneys now

San francisco, california--(newsfile corp. - april 14, 2021) - hagens berman urges fibrogen, inc. (nasdaq: fgen) investors with significant losses to submit your losses now.class period: nov. 8, 2019 - apr. 6, 2021lead plaintiff deadline: june 11, 2021visit: www.hbsslaw.com/cases/fgencontact an attorney now: fgen@hbsslaw.com844-916-0895fibrogen, inc. (nasdaq: fgen) securities fraud action: the complaint centers on fibrogen's presentation of false data of roxadustat to make the anemia drug look safer than it is.throughout the cla
FGEN Ratings Summary
FGEN Quant Ranking